Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 850 blog entries.

September 2025

Proscia to Expand Pathology AI Capabilities with Virtual Staining

2025-09-30T08:33:36+00:00

Delivering a menu of H&E, IHC, and special stains on the Concentriq platform Proscia®, a pathology AI company, is introducing virtual staining in its Concentriq® software platform to help laboratories reduce the costs associated with traditional chemical methods and drive efficiency in high-throughput workflows. The virtual staining, powered by Pictor Labs, will support the evolution from research applications [...]

Proscia to Expand Pathology AI Capabilities with Virtual Staining2025-09-30T08:33:36+00:00

Why Deploying AI in a Clinical Setting is so Darn Difficult

2025-09-26T08:48:42+00:00

The use of artificial intelligence (AI) in digital pathology has proposed faster workflows, more accurate diagnoses, and the opportunity to discover new insights that we can harness to improve patient care. Thousands of academic papers demonstrate new AI algorithms each year, yet only a handful of these ever make it into the world of clinical care.

Why Deploying AI in a Clinical Setting is so Darn Difficult2025-09-26T08:48:42+00:00

PathAI Launches Industry-Backed AIM-HI UC Model on GCP-Compliant Platform to Standardize Histological Assessment in Ulcerative Colitis Trials

2025-09-26T08:21:11+00:00

PathAI, the global leader in AI-powered pathology, today announced the integration of AIM-HI UC1, an advanced AI model for Ulcerative Colitis (UC) histology endpoint assessment, on to AISight™ Clinical Trials, PathAI’s GCP and GCLP-compliant platform. AIM-HI UC1 was developed by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium’s Mucosal Healing in Ulcerative Colitis Project [...]

PathAI Launches Industry-Backed AIM-HI UC Model on GCP-Compliant Platform to Standardize Histological Assessment in Ulcerative Colitis Trials2025-09-26T08:21:11+00:00

Artificial Intelligence in Pathology – Has Its Time Come?

2025-09-29T08:12:09+00:00

By Dr. Keith J. Kaplan Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI’s datasets from 7 million slides, perhaps most of which were from Memorial Sloan Kettering Cancer Center. Critics [...]

Artificial Intelligence in Pathology – Has Its Time Come?2025-09-29T08:12:09+00:00

Unlocking the Power of the Cloud for Digital Pathology: How Proscia and AWS Deliver a Purpose-Built SaaS Platform

2025-09-25T08:23:12+00:00

By Rupesh Mishra & Coleman Stavish Rupesh Mishra, Healthcare Solutions Architect, Amazon Web Services, and Coleman Stavish, CTO, Proscia At Proscia, we’re committed to making digital pathology effortless, scalable, and enterprise-ready for our customers. That’s why Concentriq—our flagship enterprise pathology platform—is delivered as a cloud-native SaaS solution hosted on Amazon Web Services [...]

Unlocking the Power of the Cloud for Digital Pathology: How Proscia and AWS Deliver a Purpose-Built SaaS Platform2025-09-25T08:23:12+00:00

Owkin Partners with Istituto Europeo di Oncologia (IEO) to Advance AI-driven Cancer Research and Therapeutic Development

2025-11-04T14:08:29+00:00

IEO ranks among the world's top cancer research institutes with over 18,000 patients served annually Partnership will leverage AI to identify and validate new biomarkers and therapeutic targets Collaboration includes comprehensive research initiatives and potential integration of AI tools into clinical workflows Owkin and Istituto Europeo di Oncologia (IEO) have announced a strategic partnership to [...]

Owkin Partners with Istituto Europeo di Oncologia (IEO) to Advance AI-driven Cancer Research and Therapeutic Development2025-11-04T14:08:29+00:00

Elea AI’s Advanced Pathology Information System Garners Significant Interest at 37th European Congress of Pathology

2025-09-24T16:17:56+00:00

elea AI, a developer of modern, AI-assisted software solutions for clinical practice, reports a highly successful participation at the 37th European Congress of Pathology (ECP) in Vienna. The company's advanced Pathology Information System (PIS) was a focal point of discussion, drawing strong interest from industry leaders and pathology professionals. The 37th ECP served as a key [...]

Elea AI’s Advanced Pathology Information System Garners Significant Interest at 37th European Congress of Pathology2025-09-24T16:17:56+00:00

Mindpeak Strengthens Board with Appointment of Christiaan Neeleman to Accelerate Global Expansion in AI Pathology

2025-09-24T14:06:40+00:00

Mindpeak, a global leader in AI powered pathology, today announced the appointment of Christiaan Neeleman to its Board of Directors. Neeleman  brings more than two decades of international leadership in life sciences, diagnostics and health technology, adding strategic depth as Mindpeak  accelerates its global growth and deepens its partnerships across pharma, biotech, and diagnostics. Neeleman’s significant [...]

Mindpeak Strengthens Board with Appointment of Christiaan Neeleman to Accelerate Global Expansion in AI Pathology2025-09-24T14:06:40+00:00

Proscia Expands AWS Collaboration to Advance Precision Medicine with AWS HealthImaging Integration

2025-09-24T10:53:13+00:00

AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform Proscia®, a pathology AI company, today announced the next step in its collaboration with Amazon Web Services (AWS) to address two of digital pathology’s most pressing challenges: managing surging data volumes and standardizing siloed data. It has integrated its Concentriq® platform for pathology [...]

Proscia Expands AWS Collaboration to Advance Precision Medicine with AWS HealthImaging Integration2025-09-24T10:53:13+00:00

Digital Pathology in Clinical Trials: Driving Faster Drug Development

2025-09-24T08:39:35+00:00

By Jenna Karpel Overview: The Clinical Trials Module in HALO AP Platforms The Clinical Trials module in HALO AP®, a CE-IVDR marked and AI-powered platform for primary diagnosis, and HALO AP Dx, an FDA-cleared platform for primary diagnosis, provide pathologists and researchers access to comprehensive digital pathology tools for building objective, unbiased datasets that [...]

Digital Pathology in Clinical Trials: Driving Faster Drug Development2025-09-24T08:39:35+00:00
Go to Top